All In MedTech

Device Trial Radar · NCT03016169

Trifecta™ GT Post Market Clinical Follow-up

Trifecta™ GT (Glide Technology) Post Market Clinical Follow-up (PMCF)

Last checked: Nov 20, 2026Latest source record: Feb 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

358

Actual

Start

Mar 9, 2017

Primary completion

Apr 25, 2023

Study completion Aug 31, 2023

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Jan 10, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the safety and performance of the Trifecta™ GT (Glide Technology) valve through 5 year follow-up in a prospective, multi-center, real-world setting. This study is intended to satisfy post-market clinical follow-up requirements of CE Mark in Europe.

Conditions

  • Aortic Valve Disease
  • Aortic Valve Disorder

Interventions

  • Trifecta GT (Glide Technology) ValveDevice

    Surgical aortic valve replacement with Trifecta GT Valve.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Freedom From Surgical Valve Replacement or Transcatheter Valve-in-Valve ImplantationTime frame: 5 years post implant

Locations

27 sites in 12 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Rochester, Minnesota

  • Mission Health & Hospitals

    Asheville, North Carolina

  • Main Line Health Center/Lankenau Hospital

    Wynnewood, Pennsylvania

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.